Autocrine hGH has been involved in promoting tumorigenic behaviors of breast and endometrial cancer cells, including epithelial-mesenchymal transition (EMT) [12,13] and cancer stem cell (CSC)-like properties [14]. This evidence concerns the gene GH1 and cancer.